Despite these financial challenges, the company experienced a 20% increase in sales of Primatene Mist, indicating strong market demand. Furthermore, the FDA accepted Amphastar’s Biologics License ...

Amphastar Pharmaceuticals (NASDAQ: AMPH) stock reached a 52-week low, trading at 22.6 USD. According to InvestingPro analysis, the company appears undervalued despite maintaining strong fundamentals ...

Amphastar Pharmaceuticals' first quarter results saw revenue remain flat compared to last year and fall slightly short of Wall Street’s projections, while non-GAAP earnings per share came in ...

This is a vector set of realistic powder or mist sprays, aerosol trails and bursting vapour splashes. Festive wind, Christmas spotted, cold air. Smoke from car wheels, smoke from explosions.